79 related articles for article (PubMed ID: 3006729)
1. [Adaptation to defined chemical conditions of the in vitro growth of PLC/PRF/5 cells].
Bagnarelli P; Festa A; Testa I; Manzin A; Clementi M
Boll Soc Ital Biol Sper; 1985 Oct; 61(10):1513-20. PubMed ID: 3006729
[No Abstract] [Full Text] [Related]
2. A serum-free growth of a human hepatoma cell line as a tool for hepatocarcinogenesis and virus gene expression.
Bagnarelli P; Brugia M; Clementi M
Dev Biol Stand; 1985; 60():45-53. PubMed ID: 2995177
[TBL] [Abstract][Full Text] [Related]
3. Tumorigenicity in nude mice of a human hepatoma cell line containing hepatitis B virus DNA.
Shouval D; Reid LM; Chakraborty PR; Ruiz-Opazo N; Morecki R; Gerber MA; Thung SN; Shafritz DA
Cancer Res; 1981 Apr; 41(4):1342-50. PubMed ID: 6260336
[TBL] [Abstract][Full Text] [Related]
4. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium.
Nakabayashi H; Taketa K; Miyano K; Yamane T; Sato J
Cancer Res; 1982 Sep; 42(9):3858-63. PubMed ID: 6286115
[TBL] [Abstract][Full Text] [Related]
5. [Adaptation to the cell line PLC/PRF/5 of hepatitis A virus released in the cell culture medium].
Crance JM; Passagot J; Verwaerde N; Biziagos E; Gandré H; Deloince R
C R Acad Sci III; 1985; 301(7):361-3. PubMed ID: 2998570
[TBL] [Abstract][Full Text] [Related]
6. Effect of insulin on an insulin receptor of PLC/PRF/5 human hepatoma cell line.
Testa I; Clementi M; Festa A; Bagnarelli P; Brugia M; de Martinis C
Dev Biol Stand; 1985; 60():81-91. PubMed ID: 2995179
[TBL] [Abstract][Full Text] [Related]
7. Polypeptide analysis of hepatitis virus type B surface antigen produced by a human hepatoma cell line, PLC/PRF/5.
Tobita K; Ohori K
Acta Virol; 1980 Sep; 24(5):367-70. PubMed ID: 6108067
[TBL] [Abstract][Full Text] [Related]
8. Ultrastructural analysis of hepatitis B surface antigen production in vitro.
Aoki N; Thung SN; Gerber MA
Lab Invest; 1982 Nov; 47(5):465-70. PubMed ID: 6182389
[TBL] [Abstract][Full Text] [Related]
9. Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen.
Gerber MA; Garfinkel E; Hirschman SZ; Thung SN; Panagiotatos T
J Immunol; 1981 Mar; 126(3):1085-9. PubMed ID: 6161957
[TBL] [Abstract][Full Text] [Related]
10. Further studies on production and characterization of HBsAg derived from a human hepatoma cell line (PLC/PRF/5).
Barin F; Goudeau A; Brechot C; Romet-Lemonne J; Sureau C; Lesage G
Dev Biol Stand; 1983; 54():81-92. PubMed ID: 6317496
[TBL] [Abstract][Full Text] [Related]
11. [Action of monoclonal antibody against a hepatocellular carcinoma cell line (PLC/PRF/5)].
Shao RP
Zhonghua Zhong Liu Za Zhi; 1986 Jul; 8(4):259-61. PubMed ID: 3019621
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of the antiviral and cellular antireplication effect of human interferon on a line of primary hepatocarcinoma].
Clementi M; Bagnarelli P; Frezza G; Santirocco N; Manzin A; Brugia M; Calegari L
G Ital Chemioter; 1985; 32(1):137-40. PubMed ID: 2420674
[No Abstract] [Full Text] [Related]
14. Growth kinetics of hepatocellular carcinoma.
Yoshino M
Jpn J Clin Oncol; 1983 Mar; 13(1):45-52. PubMed ID: 6187947
[TBL] [Abstract][Full Text] [Related]
15. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.
Liu L; Cao Y; Chen C; Zhang X; McNabola A; Wilkie D; Wilhelm S; Lynch M; Carter C
Cancer Res; 2006 Dec; 66(24):11851-8. PubMed ID: 17178882
[TBL] [Abstract][Full Text] [Related]
16. [Relation between the pathologic grading and the distribution of HBAg in hepatocellular carcinoma].
Wang WL
Zhonghua Zhong Liu Za Zhi; 1983 Jan; 5(1):31-3. PubMed ID: 6189684
[No Abstract] [Full Text] [Related]
17. [Effects of tumor suppressing gene TIP30/CC3 on the growth of tumor cells].
Zhang X; Ouyang XN; Li XD; Zhao J; Guo YJ
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):38-41. PubMed ID: 15670490
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of insulin-like growth factor binding proteins and growth modulation in hepatoma cells by retinoic acid.
Kim DG; Lee DY; Cho BH; You KR; Kim MY; Ahn DS
Hepatology; 1999 Apr; 29(4):1091-8. PubMed ID: 10094952
[TBL] [Abstract][Full Text] [Related]
19. Tumorigenicity and interferon properties of the PLC/PRF/5 human hepatoma cell line.
Desmyter J; De Groote G; Ray MB; Bradburne AF; Desmet V; De Somer P; Alexander J
Prog Med Virol; 1981; 27():103-8. PubMed ID: 6165050
[No Abstract] [Full Text] [Related]
20. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo.
Hitomi M; Yokoyama F; Kita Y; Nonomura T; Masaki T; Yoshiji H; Inoue H; Kinekawa F; Kurokohchi K; Uchida N; Watanabe S; Kuriyama S
Int J Oncol; 2005 Mar; 26(3):713-20. PubMed ID: 15703828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
